Back
Pharming Group NV Vs. uniQure NV Industry Stock Comparison
Sell
42
PHAR
Pharming Group NV
Last Price:
$17.10
Seasonality Move:
-2.42%
Sell
45
QURE
uniQure NV
Last Price:
$23.78
Seasonality Move:
6.03%
Sell
42
Pharming Group NV (PHAR)
is a Sell
Is Pharming Group NV a Buy, Sell or Hold?
-
The current Pharming Group NV [PHAR] share price is $16.93. The Score for PHAR is 42, which is 16% below its historic median score of 50, and infers higher risk than normal.
-
PHAR is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
45
uniQure NV (QURE)
is a Sell
Is uniQure NV a Buy, Sell or Hold?
-
The current uniQure NV [QURE] share price is $24.56. The Score for QURE is 45, which is 10% below its historic median score of 50, and infers higher risk than normal.
-
QURE is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
PHAR Stock Price Chart
What is Pharming Group NV's stock price today?
-
The Pharming Group NV share price today is $16.93Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and PHAR is experiencing selling pressure, which indicates risk of future bearish movement.
QURE Stock Price Chart
What is uniQure NV's stock price today?
-
The uniQure NV share price today is $24.56Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and QURE is experiencing selling pressure, which indicates risk of future bearish movement.
PHAR Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 4.82 | Buy |
| Relative Strength Index (14 RSI): | 50.81 | Buy |
| Chaikin Money Flow: | -4670 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | ( - ) | Buy |
| Bollinger Bands (100): | ( - ) | Buy |
QURE Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 6.83 | Buy |
| Relative Strength Index (14 RSI): | 44.41 | Sell |
| Chaikin Money Flow: | 408552 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | ( - ) | Buy |
| Bollinger Bands (100): | ( - ) | Buy |
PHAR Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 17.16 | Sell |
| 20-day SMA: | 16.99 | Sell |
| 50-day SMA: | 15.89 | Buy |
| 200-day SMA: | 12.37 | Buy |
| 8-day EMA: | 15 | Buy |
| 20-day EMA: | 9.5 | Buy |
| 50-day EMA: | 4.71 | Buy |
| 200-day EMA: | 1.32 | Buy |
QURE Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 24.33 | Buy |
| 20-day SMA: | 23.02 | Buy |
| 50-day SMA: | 34.35 | Sell |
| 200-day SMA: | 22.9 | Buy |
| 8-day EMA: | 21.27 | Buy |
| 20-day EMA: | 13.46 | Buy |
| 50-day EMA: | 6.68 | Buy |
| 200-day EMA: | 1.87 | Buy |
Pharming Group NV Earnings Growth & PHAR Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.01 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.04 per share, and an increase next year of $0.00 per share.
uniQure NV Earnings Growth & QURE Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.04 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.81 per share, and an increase next year of $1.44 per share.
Pharming Group NV Technical Analysis
| Dec 16 | Dec 17 | Dec 18 | Dec 19 | Dec 22 | Dec 23 | Dec 24 | Dec 26 | Dec 29 | Dec 30 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | ||||||||||
| 16 | 17 | 18 | 19 | 22 | 23 | 24 | 26 | 29 | 30 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
uniQure NV Technical Analysis
| Dec 16 | Dec 17 | Dec 18 | Dec 19 | Dec 22 | Dec 23 | Dec 24 | Dec 26 | Dec 29 | Dec 30 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | ||||||||||
| 16 | 17 | 18 | 19 | 22 | 23 | 24 | 26 | 29 | 30 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||